Literature DB >> 32800672

Translation and cross-cultural adaptation of the Charcot-Marie-Tooth disease Pediatric Scale to Brazilian Portuguese and determination of its measurement properties.

Karoliny Lisandra Teixeira Cruz1, Ana Cristina Resende Camargos2, Juliana Cardoso3, Cyntia Rogean de Jesus Alves de Baptista3, Aline Duprat Ramos4, Ana Claudia Mattiello-Sverzut3, Joshua Burns5, Hércules Ribeiro Leite6.   

Abstract

BACKGROUND: The Charcot-Marie-Tooth disease Pediatric Scale (CMTPedS) has been used to measure aspects of disability in children with all types of Charcot-Marie-Tooth disease (CMT).
OBJECTIVE: To translate and cross-culturally adapt the CMTPedS into Brazilian-Portuguese and determine its reliability and validity.
METHODS: The translation and cross-cultural adaptation followed international guidelines recommendations. Twenty individuals with CMT were assessed. Two examiners assessed the participants for inter-rater reliability. Face validity was assessed by eight physical therapists that judged the relevance of each test item. The Bland-Altman analysis (bias) and standard error of measurement (SEM) complemented the analysis. Furthermore, intraclass correlation coefficients (ICC), weighted kappa (k), and internal consistency (Cronbach's alpha) was determined.
RESULTS: The CMTPedS was successfully translated and cross-culturally adapted. Twenty children/youth were enrolled in the study. Of these, the majority (55%) were girls with a mean age of 13.9 (range: from 6 to 18) years. Regarding face validity, the CMTPedS-Br showed relevant items for assessing children and youth with CMT. The ICC for the total score showed excellent reliability (ICC2.1  = 0.93, 95% CI = 0.84, 0.97). The most reliable items were grip, dorsiflexion and plantar flexion strength while the least reliable items were pinprick, vibration, and gait. The internal consistency was excellent (α = 0.96, 95% CI = 0.91, 0.99) and the agreement showed small variability (bias = 0.15, 95% CI= -4.28, 4.60).
CONCLUSION: The CMTPedS-Br showed adequate reliability and face validity to measure disability in individuals with CMT. This tool will allow Brazil to be part of multicentered studies on such a rare but debilitating condition.
Copyright © 2020 Associação Brasileira de Pesquisa e Pós-Graduação em Fisioterapia. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Adolescent; Charcot-Marie-Tooth; Children; Disability scale; Neuropathy; Physical therapy

Year:  2020        PMID: 32800672      PMCID: PMC8134765          DOI: 10.1016/j.bjpt.2020.07.008

Source DB:  PubMed          Journal:  Braz J Phys Ther        ISSN: 1413-3555            Impact factor:   3.377


  33 in total

1.  Interpreting change scores of tests and measures used in physical therapy.

Authors:  Stephen M Haley; Maria A Fragala-Pinkham
Journal:  Phys Ther       Date:  2006-05

2.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

3.  Reliability, validity and description of timed performance of the Jebsen-Taylor Test in patients with muscular dystrophies.

Authors:  Mariana Cunha Artilheiro; Francis Meire Fávero; Fátima Aparecida Caromano; Acary de Souza Bulle Oliveira; Nelson Carvas; Mariana Callil Voos; Cristina Dos Santos Cardoso de Sá
Journal:  Braz J Phys Ther       Date:  2017-12-08       Impact factor: 3.377

Review 4.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

5.  Development and validation of the Charcot-Marie-Tooth Disease Infant Scale.

Authors:  Melissa R Mandarakas; Manoj P Menezes; Kristy J Rose; Rosemary Shy; Kate Eichinger; Maria Foscan; Timothy Estilow; Rachel Kennedy; Karen Herbert; Paula Bray; Kathryn Refshauge; Monique M Ryan; Eppie M Yiu; Michelle Farrar; Hugo Sampaio; Isabella Moroni; Emanuela Pagliano; Davide Pareyson; Sabrina W Yum; David N Herrmann; Gyula Acsadi; Michael E Shy; Joshua Burns; Oranee Sanmaneechai
Journal:  Brain       Date:  2018-12-01       Impact factor: 13.501

6.  Reliability of the triple-timed up-and-go test.

Authors:  Donald B Sanders; Jeffrey T Guptill; Kathy L Aleš; Lisa D Hobson-Webb; David P Jacobus; Riaz Mahmood; Janice M Massey; Melissa M Pittman; Kristi Prather; Shruti M Raja; Eric Yow; Vern C Juel
Journal:  Muscle Nerve       Date:  2017-06-06       Impact factor: 3.217

7.  Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability.

Authors:  Joshua Burns; Robert Ouvrier; Tim Estilow; Rosemary Shy; Matilde Laurá; Julie F Pallant; Monkol Lek; Francesco Muntoni; Mary M Reilly; Davide Pareyson; Gyula Acsadi; Michael E Shy; Richard S Finkel
Journal:  Ann Neurol       Date:  2012-05       Impact factor: 10.422

8.  Evolution of foot and ankle manifestations in children with CMT1A.

Authors:  Joshua Burns; Monique M Ryan; Robert A Ouvrier
Journal:  Muscle Nerve       Date:  2009-02       Impact factor: 3.217

9.  Quality-of-life in Charcot-Marie-Tooth disease: the patient's perspective.

Authors:  Nicholas E Johnson; Chad R Heatwole; Nuran Dilek; Janet Sowden; Callyn A Kirk; Denise Shereff; Michael E Shy; David N Herrmann
Journal:  Neuromuscul Disord       Date:  2014-06-27       Impact factor: 4.296

10.  Validation of the Italian version of the Charcot-Marie-Tooth disease Pediatric Scale.

Authors:  Riccardo Zuccarino; Valeria Prada; Isabella Moroni; Emanuela Pagliano; Maria Foscan; Giulia Robbiano; Chiara Pisciotta; Kayla Cornett; Rosemary Shy; Angelo Schenone; Davide Pareyson; Michael Shy; Joshua Burns
Journal:  J Peripher Nerv Syst       Date:  2020-05-26       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.